These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25880553)

  • 21. Performance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates.
    Rason MA; Randriantsoa T; Andrianantenaina H; Ratsimbasoa A; Menard D
    Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):346-51. PubMed ID: 18321546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the susceptibility of Plasmodium knowlesi and Plasmodium falciparum to antimalarial agents.
    van Schalkwyk DA; Moon RW; Blasco B; Sutherland CJ
    J Antimicrob Chemother; 2017 Nov; 72(11):3051-3058. PubMed ID: 28961865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing anti-malarial drug effects ex vivo using the haemozoin detection assay.
    Rebelo M; Tempera C; Fernandes JF; Grobusch MP; Hänscheid T
    Malar J; 2015 Apr; 14():140. PubMed ID: 25879757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of parasite genomic dynamics on the sensitivity of Plasmodium falciparum isolates to piperaquine and other antimalarial drugs.
    Wakoli DM; Ondigo BN; Ochora DO; Amwoma JG; Okore W; Mwakio EW; Chemwor G; Juma J; Okoth R; Okudo C; Yeda R; Opot BH; Cheruiyot AC; Juma D; Roth A; Ogutu BR; Boudreaux D; Andagalu B; Akala HM
    BMC Med; 2022 Nov; 20(1):448. PubMed ID: 36397090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ex vivo susceptibility and genotyping of Plasmodium falciparum isolates from Pikine, Senegal.
    Mbaye A; Gaye A; Dieye B; Ndiaye YD; Bei AK; Affara M; Deme AB; Yade MS; Diongue K; Ndiaye IM; Ndiaye T; Sy M; Sy N; Koita O; Krogstad DJ; Volkman S; Nwakanma D; Ndiaye D
    Malar J; 2017 Jun; 16(1):250. PubMed ID: 28615016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
    Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
    Sante; 2008; 18(1):43-7. PubMed ID: 18684691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing the HRP-2 in vitro malaria drug susceptibility assay using a reference clone to improve comparisons of Plasmodium falciparum field isolates.
    Rutvisuttinunt W; Chaorattanakawee S; Tyner SD; Teja-Isavadharm P; Se Y; Yingyuen K; Chaichana P; Bethell D; Walsh DS; Lon C; Fukuda M; Socheat D; Noedl H; Schaecher K; Saunders DL
    Malar J; 2012 Sep; 11():325. PubMed ID: 22974086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso.
    Tahita MC; Tinto H; Yarga S; Kazienga A; Traore Coulibaly M; Valea I; Van Overmeir C; Rosanas-Urgell A; Ouedraogo JB; Guiguemde RT; van Geertruyden JP; Erhart A; D'Alessandro U
    Malar J; 2015 Jun; 14():251. PubMed ID: 26088768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal changes in Plasmodium falciparum anti-malarial drug sensitivity in vitro and resistance-associated genetic mutations in isolates from Papua New Guinea.
    Koleala T; Karl S; Laman M; Moore BR; Benjamin J; Barnadas C; Robinson LJ; Kattenberg JH; Javati S; Wong RP; Rosanas-Urgell A; Betuela I; Siba PM; Mueller I; Davis TM
    Malar J; 2015 Jan; 14():37. PubMed ID: 25626445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia.
    Assefa A; Mohammed H; Anand A; Abera A; Sime H; Minta AA; Tadesse M; Tadesse Y; Girma S; Bekele W; Etana K; Alemayehu BH; Teka H; Dilu D; Haile M; Solomon H; Moriarty LF; Zhou Z; Svigel SS; Ezema B; Tasew G; Woyessa A; Hwang J; Murphy M
    Malar J; 2022 Dec; 21(1):359. PubMed ID: 36451216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Variant PfCRT Isoform Can Contribute to
    Dhingra SK; Redhi D; Combrinck JM; Yeo T; Okombo J; Henrich PP; Cowell AN; Gupta P; Stegman ML; Hoke JM; Cooper RA; Winzeler E; Mok S; Egan TJ; Fidock DA
    mBio; 2017 May; 8(3):. PubMed ID: 28487425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of malaria in vitro drug combination screening and mixed-strain infections using the malaria Sybr green I-based fluorescence assay.
    Co EM; Dennull RA; Reinbold DD; Waters NC; Johnson JD
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2557-63. PubMed ID: 19349518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Piperaquine resistant Cambodian Plasmodium falciparum clinical isolates: in vitro genotypic and phenotypic characterization.
    Boonyalai N; Vesely BA; Thamnurak C; Praditpol C; Fagnark W; Kirativanich K; Saingam P; Chaisatit C; Lertsethtakarn P; Gosi P; Kuntawunginn W; Vanachayangkul P; Spring MD; Fukuda MM; Lon C; Smith PL; Waters NC; Saunders DL; Wojnarski M
    Malar J; 2020 Jul; 19(1):269. PubMed ID: 32711538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation of Plasmodium falciparum in vitro drug resistance phenotype following culture adaptation compared to fresh clinical isolates in Cambodia.
    Chaorattanakawee S; Lanteri CA; Sundrakes S; Yingyuen K; Gosi P; Chanarat N; Wongarunkochakorn S; Buathong N; Chann S; Kuntawunginn W; Arsanok M; Lin JT; Juliano JJ; Tyner SD; Char M; Lon C; Saunders DL
    Malar J; 2015 Dec; 14():486. PubMed ID: 26626127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening.
    Johnson JD; Dennull RA; Gerena L; Lopez-Sanchez M; Roncal NE; Waters NC
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1926-33. PubMed ID: 17371812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil.
    Aguiar AC; Pereira DB; Amaral NS; De Marco L; Krettli AU
    Malar J; 2014 Feb; 13():73. PubMed ID: 24581308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory activity of ferroquine, versus chloroquine, against western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay.
    Eyase FL; Akala HM; Johnson JD; Walsh DS
    Am J Trop Med Hyg; 2011 Dec; 85(6):984-8. PubMed ID: 22144431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates.
    Foguim FT; Bogreau H; Gendrot M; Mosnier J; Fonta I; Benoit N; Amalvict R; Madamet M; Wein S; Pradines B;
    Malar J; 2020 Jun; 19(1):201. PubMed ID: 32503540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia.
    Marfurt J; Wirjanata G; Prayoga P; Chalfein F; Leonardo L; Sebayang BF; Apriyanti D; Sihombing MAEM; Trianty L; Suwanarusk R; Brockman A; Piera KA; Luo I; Rumaseb A; MacHunter B; Auburn S; Anstey NM; Kenangalem E; Noviyanti R; Russell B; Poespoprodjo JR; Price RN
    Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():46-56. PubMed ID: 34193398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.